Lexston Life Sciences Corp. (LEXT) Stock Price & Analysis

LEXT Stock Chart & Stats

CA$0.05CA$0.00(0.00%)

At close: Nov 02 9:30 AM EST

Day’s Range: CAD 0.04 - CAD 0.05
52-Week Range: CAD 0.03 - CAD 0.34
Previous Close: CAD 0.05
Volume: N/A
Average Volume (3M): 54.92K
Market Cap: CAD 1.31M
Enterprise Value: CAD 2.01M
Total Cash (Recent Filing): CAD 6,570
Total Debt (Recent Filing): CAD 0
Price to Earnings (P/E): ―
Beta: 0.03
Next Earnings: Jan 06, 2027 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

Debt-Free Balance Sheet

The absence of reported debt reduces interest obligations and near-term solvency pressure, giving the company more flexibility than a similarly loss-making business with leverage. This benefit is meaningful over the next several months, although it does not offset weak operating performance.

Equity Recovery

The recovery in shareholder equity during 2026 indicates some balance-sheet improvement after the prior decline. If maintained, a stronger equity base could provide greater resilience against ongoing losses, though the company still has limited capacity to absorb continued cash burn.

Modest Cash-Flow Improvement

A modest improvement in free cash flow shows that cash deterioration has not worsened uniformly across every period. This is a limited positive because operating and free cash flow remain negative, but continued improvement could eventually reduce the company’s dependence on external financing.

Bears Say

No Recent Revenue

The absence of reported revenue leaves the company without demonstrated commercial traction and makes operating leverage impossible to establish. Unless revenue returns and becomes repeatable, investors cannot rely on a functioning revenue engine to support expenses or fund future growth.

Persistent Operating Losses

Persistent and sizable operating and net losses show that profitability has not stabilized. With no meaningful recent revenue base, the company lacks evidence that fixed costs can be covered or that scale benefits will emerge, keeping earnings power structurally uncertain over the next several quarters.

Sustained Cash Burn

Continued negative operating and free cash flow means the business is not yet self-funding and must preserve access to financing to continue operating. Ongoing cash burn can erode financial flexibility and may require additional funding before a durable operating improvement is visible.

Lexston Life Sciences Corp. News

Lexston Mining Grants Stock Options to Bolster Exploration-Stage Growth

Lexston Life Sciences Corp. ( ($TSE:LEXT) ) has provided an announcement. Lexston Mining Corporation, a Canadian mineral explorer with projects in British Columbia and Nevada and acquisition plans in Guyana,

3d agoLEXT

Lexston Mining Shareholders Back Board, Auditor and Stock Option Plan at AGM

The latest announcement is out from Lexston Life Sciences Corp. ( ($TSE:LEXT) ). Lexston Mining Corporation reported that shareholders approved all matters at its annual general and special meeting held

1M agoLEXT

Lexston Mining Grants Stock Options to Align Stakeholder Interests

An update from Lexston Life Sciences Corp. ( ($TSE:LEXT) ) is now available. Lexston Mining Corporation has granted incentive stock options to directors, officers and consultants to purchase up to

2M agoLEXT

Lexston Mining Begins Phase 1 Exploration at Nevada’s Garfield Hills Property

Lexston Life Sciences Corp. ( ($TSE:LEXT) ) has issued an update. Lexston Mining Corporation has engaged Geophasic Exploration LLC to launch Phase 1 of its exploration program at the Garfield

9M agoLEXT

Lexston Mining Grants Stock Options to Align Management With Exploration Strategy

An announcement from Lexston Life Sciences Corp. ( ($TSE:LEXT) ) is now available. Lexston Mining Corporation has granted incentive stock options to directors, officers and consultants to purchase up to

9M agoLEXT

Lexston Mining Raises $500,000 in Fully Subscribed Private Placement

Lexston Life Sciences Corp. ( ($TSE:LEXT) ) has shared an update. Lexston Mining Corporation has closed a fully subscribed non-brokered private placement, raising $500,000 through the issuance of 6,250,000 units

9M agoLEXT

Lexston Mining Launches $500,000 Private Placement to Fund Exploration

Lexston Life Sciences Corp. ( ($TSE:LEXT) ) has issued an announcement. Lexston Mining Corporation has announced a non-brokered private placement of up to 6,250,000 units at $0.08 per unit, seeking

10M agoLEXT

Lexston Strengthens Advisory Team with Veteran Appointment and Grants Stock Options

Lexston Life Sciences Corp. ( ($TSE:LEXT) ) just unveiled an update. Lexston Mining Corporation has announced the appointment of Buddy Doyle to its new Advisory Board, marking a significant step

10M agoLEXT

Lexston Mining Corporation Secures Garfield Hills Property in Nevada

The latest announcement is out from Lexston Life Sciences Corp. ( ($TSE:LEXT) ). Lexston Mining Corporation has entered into a definitive Assignment Agreement to acquire 128 mineral claims at the

11M agoLEXT

Lexston Mining Eyes Expansion with Garfield Hills Property Acquisition

Lexston Life Sciences Corp. ( ($TSE:LEXT) ) just unveiled an announcement. Lexston Mining Corporation has signed a memorandum of understanding to potentially acquire 128 mineral claims at the Garfield Hills

11M agoLEXT

LEXT FAQ

What was Lexston Life Sciences Corp.’s price range in the past 12 months?

Lexston Life Sciences Corp. lowest stock price was C$0.03 and its highest was C$0.34 in the past 12 months.

What is Lexston Life Sciences Corp.’s market cap?

Lexston Life Sciences Corp.’s market cap is C$1.31M.

When is Lexston Life Sciences Corp.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Lexston Life Sciences Corp.’s earnings last quarter?

Lexston Life Sciences Corp. released its earnings results on Sep 16, 2026. The company reported -C$0.016 earnings per share for the quarter.

Is Lexston Life Sciences Corp. overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Lexston Life Sciences Corp. pay dividends?

Lexston Life Sciences Corp. does not currently pay dividends.

What is Lexston Life Sciences Corp.’s EPS estimate?

Lexston Life Sciences Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Lexston Life Sciences Corp. have?

Lexston Life Sciences Corp. has 26,238,218 shares outstanding.

What happened to Lexston Life Sciences Corp.’s price movement after its last earnings report?

Lexston Life Sciences Corp. reported an EPS of -C$0.016 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Lexston Life Sciences Corp.?

Currently, no hedge funds are holding shares in TSE:LEXT

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description